glp-1 lexington The Latest on GLP-1s | Medical Center Blog GLP-1 Agonists: A Comprehensive Overview

FDA updates rules on compounded GLP-1 drugs, impacting patients and providers

Alex Zhavoronkov, discussed how the GLP-1 revolution is expanding beyond weight loss toward healthy longevity

If your symptoms are persistent or severe, contact your provider promptly.Schedule a consultation today to speak to a MacArthur Weight Management Specialist.

During the consumption period, 8.5 g of d-allulose was consumed by the participants before iftar meal

Metabolic dysfunction-associated steatotic liver disease (MASLD) is currently a pressing public health issue associated with adverse outcomes such as cirrhosis, malignancy, transplantation, and mortality

Glucagon-like peptide-1 receptor agonists significantly reduced alanine aminotransferase levels in pediatric metabolic dysfunction-associated steatotic liver disease, especially those with type 2 diabetes, researchers reported